  The worldwide incidence of obesity , defined as a BMI â‰¥ 30 kg/m2 , has more than doubled during the past four decades. Bariatric/metabolic surgery provides the largest and most sustainable degree of weight<symptom> loss<symptom>. This review briefly summarises the emerging randomised evidence of the superiority of these procedures over conventional treatment , in achieving glycaemic control and inducing remission in patients with type 2 diabetes as well as the observational evidence suggesting improvements in the long-term risks of cardiovascular outcomes and mortality.